# EDGAR Filing Document

**Accession Number:** 0002079720
**File Stem:** 0000000000-25-011606
**Filing Date:** 2025-12
**Character Count:** 6745
**Document Hash:** db6bcb4c6b12adaa9bbe5e798c72b07b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-011606.hdr.sgml**: 20260416

**ACCESSION NUMBER**: 0000000000-25-011606

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251216

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BUDA JUICE, INC.
- **CENTRAL INDEX KEY:** 0002079720
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 464069365
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-289874

**BUSINESS ADDRESS:**
- **STREET 1:** 4030 BLACK GOLD DRIVE
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75247
- **BUSINESS PHONE:** 214-742-9999

**MAIL ADDRESS:**
- **STREET 1:** 4030 BLACK GOLD DRIVE
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75247

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Buda Juice LLC
- **DATE OF NAME CHANGE:** 20250801
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001493152-25-012359

## Text-Extract

```

                                                             December 16, 2025

Horatio Lonsdale-Hands
Chief Executive Officer
Buda Juice, LLC
4030 Black Gold Drive,
Dallas, Texas 75247

       Re: Buda Juice, LLC
           Amendment No. 5 to Registration Statement on Form S-1
           Filed December 12, 2025
           File No. 333-289874
Dear Horatio Lonsdale-Hands:

     We have reviewed your amended registration statement and have the
following
comments.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our December 9,
2025 letter.

Amendment No. 5 to Registration Statement on Form S-1
Risk Factors
Risks Relating to This Offering
Our Certificate of Incorporation contains an exclusive forum provision for
certain claims...,
page 31

1.     We note your revisions in response to prior comment 1 and reissue in
part. Please
       address the part of that comment that requests disclosure of the risks
related to
       increased costs to bring a claim. We also note disclosure here that the
exclusive forum
       provision does not apply to actions arising under the Exchange Act or
Securities Act
       and on page 69 that your Certificate of Incorporation    provides that
unless we consent
       in writing to the selection of an alternative forum, the federal
district courts of the
       United States of America shall be the exclusive forum for the resolution
of any
 December 16, 2025
Page 2

       complaint asserting a cause of action arising under the Securities Act.
  However,
       these provisions do not appear in your Certificate of Incorporation.
Please reconcile
       your disclosures or as appropriate revise your governing documents to
clearly state
       that the exclusive forum provision does not apply to actions arising
under the
       Securities Act or Exchange Act.
Principal Stockholders, page 65

2.     We note your revisions in response to prior comment 5 and reissue in
part. Please tell
       us how you calculated the total in the    All directors and executive
officers as a group
       row under the    Beneficial Ownership After the Offering Common Stock
column. In
       this regard, it appears that Horatio Lonsdale-Hands   s beneficial
ownership should
       reflect the Stock Redemption of 500,000 shares per footnote (5).
However, the
       difference between the    Beneficial Ownership Before the Offering
Common Stock
       and    Beneficial Ownership After the Offering Common Stock    columns
is 666,667,
       instead of 500,000.
3.     We note that Marie Quintana will beneficially own 33,333 shares of the
Company
       while none of the other directors' beneficial ownership will increase
after the offering.
       We also note the disclosure on page 63 that the Company will be
compensating its
       non-employee directors with equity awards upon completion of the Company
  s listing
       on NYSE. With a view toward disclosure, please explain each directors'
beneficial
       ownership after the offering to reconcile with the director compensation
disclosure on
       page 63. As applicable, please also revise to elaborate on any
compensatory plan,
       contract or arrangement with Ms. Quintana here and in the Executive and
Director
       Compensation section, and file the compensatory plan, contract or
arrangement
       pursuant to Item 601(b)(10) of Regulation S-K and update the exhibit
index.
Part II Information Not Required in Prospectus
Item 16. Exhibits and Financial Statement Schedules.
Exhibit 5.1 Opinion of Lucosky Brookman LLP, page II-2

4.     We note that you revised your opinion to cover 266,667 Representatives
 Warrants
       and Representatives    Warrant Shares from the prior 306,667. Please
       revise Exhibit 5.1 to cover the over-allotment option for the
Representatives
       Warrants and Representatives    Warrant Shares.
General

5.     Please revise disclosures throughout the filing to update and/or
reconcile apparent
       inconsistencies, including the following:
           We note your revisions to prior comment 10 and reissue in part.
Reconcile
           references to    articles of incorporation and bylaws    and
certificate of
           incorporation and bylaws    to clarify if these titles refer to the
same documents.
           Refer to pages 29, 66 and II-2.
           Refer to your footnote     on page II-2 regarding certain
redactions. We note that
           none of the exhibits in the exhibit index is marked with footnote
 and those
           redactions do not appear in the filed exhibits. Please advise or
revise.
 December 16, 2025
Page 3

       Please contact Jeff Gordon at 202-551-3866 or Kevin Woody at
202-551-3629 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Jenny O'Shanick at 202-551-8005 or Anne Parker at 202-551-3611 with any
other
questions.

                                                         Sincerely,

                                                         Division of
Corporation Finance
                                                         Office of
Manufacturing
cc:   Soyoung Lee

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._